Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H28N2O2.CH4O3S |
Molecular Weight | 388.522 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.CCN(CC)C(COC(=O)C1=CC=C(N)C=C1)CC(C)C
InChI
InChIKey=RFPVXZWXDPIKSD-UHFFFAOYSA-N
InChI=1S/C17H28N2O2.CH4O3S/c1-5-19(6-2)16(11-13(3)4)12-21-17(20)14-7-9-15(18)10-8-14;1-5(2,3)4/h7-10,13,16H,5-6,11-12,18H2,1-4H3;1H3,(H,2,3,4)
Molecular Formula | C17H28N2O2 |
Molecular Weight | 292.4164 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | CH4O3S |
Molecular Weight | 96.106 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Additional observations on the treatment of myocardial infarct in old age with Panthesin and Hydergin (PH 203)]. | 1961 Feb 24 |
|
[TREATMENT OF APOPLEXY WITH PANTHESIN-HYDERGIN]. | 1964 Aug 21 |
|
[Comparative studies on prevention of thromboembolism using panthesin-hydergin]. | 1971 Apr |
|
[Prevention of thromboembolism in meniscus surgery using Panthesin-Hydergin]. | 1974 Dec |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:58:30 GMT 2023
by
admin
on
Sat Dec 16 10:58:30 GMT 2023
|
Record UNII |
72E501K01E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m272
Created by
admin on Sat Dec 16 10:58:30 GMT 2023 , Edited by admin on Sat Dec 16 10:58:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
135-44-4
Created by
admin on Sat Dec 16 10:58:30 GMT 2023 , Edited by admin on Sat Dec 16 10:58:30 GMT 2023
|
PRIMARY | |||
|
72E501K01E
Created by
admin on Sat Dec 16 10:58:30 GMT 2023 , Edited by admin on Sat Dec 16 10:58:30 GMT 2023
|
PRIMARY | |||
|
100000086666
Created by
admin on Sat Dec 16 10:58:30 GMT 2023 , Edited by admin on Sat Dec 16 10:58:30 GMT 2023
|
PRIMARY | |||
|
101618
Created by
admin on Sat Dec 16 10:58:30 GMT 2023 , Edited by admin on Sat Dec 16 10:58:30 GMT 2023
|
PRIMARY | |||
|
205-191-6
Created by
admin on Sat Dec 16 10:58:30 GMT 2023 , Edited by admin on Sat Dec 16 10:58:30 GMT 2023
|
PRIMARY | |||
|
DTXSID30928849
Created by
admin on Sat Dec 16 10:58:30 GMT 2023 , Edited by admin on Sat Dec 16 10:58:30 GMT 2023
|
PRIMARY | |||
|
SUB02898MIG
Created by
admin on Sat Dec 16 10:58:30 GMT 2023 , Edited by admin on Sat Dec 16 10:58:30 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |